ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 130 filers reported holding ARCUS BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,068,965 | +46.3% | 135,848 | +81.4% | 0.00% | – |
| Q1 2024 | $1,414,282 | -77.7% | 74,909 | -77.4% | 0.00% | -100.0% |
| Q4 2023 | $6,331,459 | +216.9% | 331,490 | +197.8% | 0.00% | +100.0% |
| Q3 2023 | $1,997,817 | -65.9% | 111,299 | -61.4% | 0.00% | -50.0% |
| Q2 2023 | $5,857,587 | +803.0% | 288,409 | +711.0% | 0.00% | – |
| Q1 2023 | $648,651 | +21.3% | 35,562 | +37.5% | 0.00% | – |
| Q4 2022 | $534,867 | -39.6% | 25,864 | -23.5% | 0.00% | – |
| Q3 2022 | $885,000 | +188.3% | 33,831 | +179.5% | 0.00% | – |
| Q2 2022 | $307,000 | -60.9% | 12,106 | -51.3% | 0.00% | – |
| Q1 2022 | $785,000 | +288.6% | 24,861 | +397.2% | 0.00% | – |
| Q4 2021 | $202,000 | -74.3% | 5,000 | -77.8% | 0.00% | – |
| Q3 2021 | $786,000 | +39.9% | 22,515 | +12.6% | 0.00% | – |
| Q1 2021 | $562,000 | +146.5% | 19,997 | +127.2% | 0.00% | – |
| Q4 2020 | $228,000 | -57.5% | 8,803 | -71.9% | 0.00% | – |
| Q3 2020 | $537,000 | -48.3% | 31,310 | -25.4% | 0.00% | – |
| Q2 2020 | $1,038,000 | +221.4% | 41,955 | +40.1% | 0.00% | -100.0% |
| Q4 2018 | $323,000 | – | 29,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,842,077 | $64,233,000 | 17.21% |
| Octagon Capital Advisors LP | 970,164 | $33,830,000 | 8.33% |
| Copernicus Capital Management, LLC | 17,000 | $593,000 | 7.18% |
| EcoR1 Capital, LLC | 5,122,359 | $178,617,000 | 6.21% |
| BVF INC/IL | 3,229,822 | $112,624,000 | 4.39% |
| PFM Health Sciences, LP | 3,431,010 | $119,639,000 | 3.52% |
| Alphabet Inc. | 4,100,475 | $142,984,000 | 3.39% |
| Boxer Capital, LLC | 2,084,883 | $72,700,000 | 2.54% |
| SECTORAL ASSET MANAGEMENT INC | 739,010 | $25,769,000 | 2.14% |
| Parkman Healthcare Partners LLC | 236,637 | $8,252,000 | 2.09% |